Mayberry Pharmacy Limited - Period Ending 2019-12-31

Mayberry Pharmacy Limited - Period Ending 2019-12-31


Mayberry Pharmacy Limited 03812234 false 2019-01-01 2019-12-31 2019-12-31 The principal activity of the company is Seven Pharmacy Stores and a Wholesale pharmacy business Digita Accounts Production Advanced 6.26.9041.0 Software true 03812234 2019-01-01 2019-12-31 03812234 2019-12-31 03812234 bus:OrdinaryShareClass1 2019-12-31 03812234 bus:OrdinaryShareClass2 2019-12-31 03812234 bus:OrdinaryShareClass3 2019-12-31 03812234 bus:OrdinaryShareClass4 2019-12-31 03812234 core:OtherReservesSubtotal 2019-12-31 03812234 core:RetainedEarningsAccumulatedLosses 2019-12-31 03812234 core:ShareCapital 2019-12-31 03812234 core:CurrentFinancialInstruments 2019-12-31 03812234 core:CurrentFinancialInstruments core:WithinOneYear 2019-12-31 03812234 core:Non-currentFinancialInstruments core:AfterOneYear 2019-12-31 03812234 core:Goodwill 2019-12-31 03812234 core:OtherResidualIntangibleAssets 2019-12-31 03812234 core:MoreThanFiveYears 1 2019-12-31 03812234 core:FurnitureFittingsToolsEquipment 2019-12-31 03812234 core:LandBuildings 2019-12-31 03812234 core:MotorVehicles 2019-12-31 03812234 core:OtherPropertyPlantEquipment 2019-12-31 03812234 bus:SmallEntities 2019-01-01 2019-12-31 03812234 bus:AuditExemptWithAccountantsReport 2019-01-01 2019-12-31 03812234 bus:FullAccounts 2019-01-01 2019-12-31 03812234 bus:SmallCompaniesRegimeForAccounts 2019-01-01 2019-12-31 03812234 bus:RegisteredOffice 2019-01-01 2019-12-31 03812234 bus:CompanySecretaryDirector1 2019-01-01 2019-12-31 03812234 bus:Director2 2019-01-01 2019-12-31 03812234 bus:OrdinaryShareClass1 2019-01-01 2019-12-31 03812234 bus:OrdinaryShareClass2 2019-01-01 2019-12-31 03812234 bus:OrdinaryShareClass3 2019-01-01 2019-12-31 03812234 bus:OrdinaryShareClass4 2019-01-01 2019-12-31 03812234 bus:PrivateLimitedCompanyLtd 2019-01-01 2019-12-31 03812234 core:Goodwill 2019-01-01 2019-12-31 03812234 core:OtherResidualIntangibleAssets 2019-01-01 2019-12-31 03812234 core:FurnitureFittingsToolsEquipment 2019-01-01 2019-12-31 03812234 core:LandBuildings 2019-01-01 2019-12-31 03812234 core:MotorVehicles 2019-01-01 2019-12-31 03812234 core:OtherPropertyPlantEquipment 2019-01-01 2019-12-31 03812234 core:PlantMachinery 2019-01-01 2019-12-31 03812234 core:AllAssociates 2019-01-01 2019-12-31 03812234 core:KeyManagementPersonnel 2019-01-01 2019-12-31 03812234 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2019-01-01 2019-12-31 03812234 countries:AllCountries 2019-01-01 2019-12-31 03812234 2018-12-31 03812234 core:Goodwill 2018-12-31 03812234 core:OtherResidualIntangibleAssets 2018-12-31 03812234 core:FurnitureFittingsToolsEquipment 2018-12-31 03812234 core:LandBuildings 2018-12-31 03812234 core:MotorVehicles 2018-12-31 03812234 core:OtherPropertyPlantEquipment 2018-12-31 03812234 2018-01-01 2018-12-31 03812234 2018-12-31 03812234 bus:OrdinaryShareClass1 2018-12-31 03812234 bus:OrdinaryShareClass2 2018-12-31 03812234 bus:OrdinaryShareClass3 2018-12-31 03812234 bus:OrdinaryShareClass4 2018-12-31 03812234 core:OtherReservesSubtotal 2018-12-31 03812234 core:RetainedEarningsAccumulatedLosses 2018-12-31 03812234 core:ShareCapital 2018-12-31 03812234 core:CurrentFinancialInstruments 2018-12-31 03812234 core:CurrentFinancialInstruments core:WithinOneYear 2018-12-31 03812234 core:Non-currentFinancialInstruments core:AfterOneYear 2018-12-31 03812234 core:Goodwill 2018-12-31 03812234 core:OtherResidualIntangibleAssets 2018-12-31 03812234 core:MoreThanFiveYears 1 2018-12-31 03812234 core:FurnitureFittingsToolsEquipment 2018-12-31 03812234 core:LandBuildings 2018-12-31 03812234 core:MotorVehicles 2018-12-31 03812234 core:OtherPropertyPlantEquipment 2018-12-31 03812234 bus:OrdinaryShareClass4 2018-01-01 2018-12-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 03812234

Mayberry Pharmacy Limited

Filleted Annual Report and Unaudited Financial Statements

for the Year Ended 31 December 2019

 

Mayberry Pharmacy Limited

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Financial Statements

4 to 11

 

Mayberry Pharmacy Limited

Company Information


 

Directors

Mrs JM Mayberry

Mr PR Mayberry

Company secretary

Mrs JM Mayberry

Registered office

175 High Street
Blackwood
Gwent
NP12 1AA

Accountants

HSJ Accountants Ltd
Severn House
Hazell Drive
Newport
South Wales
NP10 8FY

 

Mayberry Pharmacy Limited

(Registration number: 03812234)
Balance Sheet as at 31 December 2019

Note

2019
£

2018
£

Fixed assets

 

Intangible assets

4

2,278,452

970,159

Tangible assets

5

451,503

437,206

 

2,729,955

1,407,365

Current assets

 

Stocks

6

311,175

467,165

Debtors

7

1,441,472

1,646,899

Cash at bank and in hand

 

434,158

146,288

 

2,186,805

2,260,352

Creditors: Amounts falling due within one year

8

(2,160,560)

(1,625,750)

Net current assets

 

26,245

634,602

Total assets less current liabilities

 

2,756,200

2,041,967

Creditors: Amounts falling due after more than one year

8

(1,460,804)

(1,546,901)

Provisions for liabilities

(800,000)

(30,473)

Net assets

 

495,396

464,593

Capital and reserves

 

Called up share capital

9

6,620

6,520

Other reserves

1,808,293

-

Profit and loss account

(1,319,517)

458,073

Total equity

 

495,396

464,593

 

Mayberry Pharmacy Limited

(Registration number: 03812234)
Balance Sheet as at 31 December 2019

For the financial year ending 31 December 2019 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

Approved and authorised by the Board on 28 May 2021 and signed on its behalf by:
 

.........................................

Mr PR Mayberry
Director

 

Mayberry Pharmacy Limited

Notes to the Financial Statements for the Year Ended 31 December 2019

1

General information

The company registration number is: 03812234

The company is a private company limited by share capital, incorporated in UK.

The address of its registered office is:
175 High Street
Blackwood
Gwent
NP12 1AA
Wales

These financial statements were authorised for issue by the Board on 28 May 2021.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements were prepared in accordance with Financial Reporting Standard 102 Section 1A 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared on a going concern basis using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of Value Added Tax; net of returns, rebates and discounts; and after eliminating sales between departments within the company.

The company recognises revenue in its statutory financial statements when:
- the amount of revenue can be reliably measured;
- it is reasonably certain that future economic benefits will flow to the entity;
- and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

Mayberry Pharmacy Limited

Notes to the Financial Statements for the Year Ended 31 December 2019

Deferred income tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred income tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Leasehold land and buildings

on a straight-line basis over the duration of the lease

Furniture, fittings and equipment

on a straight-line basis over 10 years

Motor vehicles

on a straight-line basis over 5 years

Other property, plant and equipment

on a straight-line basis over 10 years

Intangible assets

Intangible assets will be carried at market value determined by the directors. Any movement in the carrying value of the intangible asset will be offset by a movement in non-distributable reserves.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Intangible assets

not amortised

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

 

Mayberry Pharmacy Limited

Notes to the Financial Statements for the Year Ended 31 December 2019

Stocks

Stocks comprise goods for resale, and are independently and professionally valued on a FIFO basis at standard replacement cost, net of Value Added Tax.

Expired or otherwise unsellable stocks are excluded from inventory.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the Statement of Income and Retained Earnings over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Provisions

Provisions are recognised when the company has an obligation at the reporting date as a result of a past event, it is probable that the company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease. Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessee.

Assets held under finance leases are recognised at the lower of their fair value at inception of the lease and the present value of the minimum lease payments. These assets are depreciated on a straight-line basis over the shorter of the useful life of the asset and the lease term. The corresponding liability to the lessor is included in the Balance Sheet as a finance lease obligation.

Lease payments are apportioned between finance costs in the Profit and Loss Account and reduction of the lease obligation so as to achieve a constant periodic rate of interest on the remaining balance of the liability.

 

Mayberry Pharmacy Limited

Notes to the Financial Statements for the Year Ended 31 December 2019

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 67 (2018 - 66).

 

Mayberry Pharmacy Limited

Notes to the Financial Statements for the Year Ended 31 December 2019

4

Intangible assets

Intangible assets
£

Other intangible assets
 £

Total
£

Cost or valuation

At 1 January 2019

4,100,995

500,000

4,600,995

Revaluations

1,808,293

-

1,808,293

Disposals

-

(500,000)

(500,000)

At 31 December 2019

5,909,288

-

5,909,288

Amortisation

At 1 January 2019

3,630,836

-

3,630,836

At 31 December 2019

3,630,836

-

3,630,836

Carrying amount

At 31 December 2019

2,278,452

-

2,278,452

At 31 December 2018

470,159

500,000

970,159

5

Tangible assets

Leasehold improvements
£

Furniture, fittings and equipment
 £

Motor vehicles
 £

Other tangible assets
£

Total
£

Cost or valuation

At 1 January 2019

395,808

452,555

6,860

150,584

1,005,807

Additions

58,233

10,876

-

42,152

111,261

At 31 December 2019

454,041

463,431

6,860

192,736

1,117,068

Depreciation

At 1 January 2019

256,213

286,493

4,239

21,656

568,601

Charge for the year

37,786

42,592

1,336

15,250

96,964

At 31 December 2019

293,999

329,085

5,575

36,906

665,565

Carrying amount

At 31 December 2019

160,042

134,346

1,285

155,830

451,503

At 31 December 2018

139,595

166,062

2,621

128,928

437,206

 

Mayberry Pharmacy Limited

Notes to the Financial Statements for the Year Ended 31 December 2019

6

Stocks

2019
£

2018
£

Other inventories

311,175

467,165

7

Debtors

Note

2019
£

2018
£

Trade debtors

 

494,444

516,308

Amounts owed by group undertakings and undertakings in which the company has a participating interest

11

495,152

548,368

Prepayments

 

72,154

52,732

Other debtors

 

379,722

529,491

 

1,441,472

1,646,899

8

Creditors

Creditors: amounts falling due within one year

2019
£

2018
£

Due within one year

Bank loans and overdrafts

1,086,910

477,018

Trade creditors

1,009,719

1,064,437

Taxation and social security

22,200

20,233

Accruals and deferred income

25,650

51,073

Other creditors

16,081

12,989

2,160,560

1,625,750

Creditors include bank loans and overdrafts and net obligations under finance lease and hire purchase contracts which are secured of £112,890 (2018 - £110,091).

 

Mayberry Pharmacy Limited

Notes to the Financial Statements for the Year Ended 31 December 2019

Creditors: amounts falling due after more than one year

Note

2019
£

2018
£

Due after one year

 

Loans and borrowings

1,460,804

1,546,901

2019
£

2018
£

Due after more than five years

After more than five years by instalments

1,067,746

1,122,519

-

-

Creditors include bank loans and overdrafts and net obligations under finance lease and hire purchase contracts which are secured of £1,460,804 (2018 - £1,546,901).

9

Share capital

Allotted, called up and fully paid shares

 

2019

2018

 

No.

£

No.

£

Ordinary shares of £1 each

2,000

2,000

2,000

2,000

E class shares of £0.01 each

450,000

4,500.00

450,000

4,500.00

B class shares of £1 each

20

20

20

20

C class shares of £1 (2018 - £0) each

100

100

-

-

 

452,120

6,620

452,020

6,520

New shares allotted

During the year 100 C class shares having an aggregate nominal value of £100 were allotted for an aggregate consideration of £100.

10

Financial commitments, guarantees and contingencies

Amounts disclosed in the balance sheet

Included in the balance sheet are contingencies of £800,000 (2018 - £Nil). This is related to ongoing negotiations with HMRC for which the final settlement figure is still uncertain. This is expected to be settled in the 2021 accounting period.

 

Mayberry Pharmacy Limited

Notes to the Financial Statements for the Year Ended 31 December 2019

11

Related party transactions

Key management personnel

Relationship: Director

Summary of transactions with key management

During the year the director made unsecured, interest free, repayable on demand loans to the company. At the balance sheet date the amount owed to the director was £104,485 (2018 - £88,642).
 

Summary of transactions with associates

Unit 10 Distribution Limited
 Unit 10 Distribution Limited has a common director and shareholder. At the balance sheet date the amount due from Unit 10 Distribution Limited was £495,152 (2018 - £548,368).